Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
October 12, 2025Diabetes Obesity and MetabolismOpen Access

Partial non‐adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross‐sectional study using blood plasma analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

VŠVojtěch ŠkopILIvana LaňkováSASimona Antalová

Discussion

Loading...

Member takes

Overview

Cross-sectional analysis reveals non-adherence rates in type 2 diabetes patients, highlighting treatment complexity's role in glycemic control.

Key Points

  • Partial non-adherence to antidiabetic therapy strongly correlates with treatment complexity and poor glycemic control.
  • Around 63% of non-adherent type 2 diabetes patients failed to achieve target glucose and HbA1c levels.
  • Plasma drug measurements using LC–MS show metformin adherence at 98.1%, while non-adherence is prevalent for other antidiabetics.
  • The study indicates the necessity for personalized strategies to enhance adherence and improve diabetes management.

Cite This Study

Škop et al. (2025) studied this question.

synapsesocial.com/papers/68ebabe3155248a327effb1bhttps://doi.org/10.1111/dom.70174
View Full Paper
Ask AI
Bookmark
Share